Phase 2 Study of BACOPP (Bleomycin, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone) in Older Patients With Hodgkin Lymphoma: A Report From the German Hodgkin Study Group (GHSG)

Blood - United States
doi 10.1182/blood-2009-11-253211
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

The Prognostic Impact of Variant Histology in Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group (GHSG)

Blood
BiochemistryImmunologyCell BiologyHematology
2013English

Treatment of Relapsed and Refractory Hodgkin Lymphoma – Recommendations of the Czech Hodgkin Lymphoma Study Group

Klinicka Onkologie
Oncology
2016English

A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin's Lymphoma

British Journal of Haematology
Hematology
2015English

A Phase II Study to Evaluate Lenalidomide in Combination With Metronomic-Dose Cyclophosphamide in Patients With Heavily Pretreated Classical Hodgkin Lymphoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2015English

A Phase 2 Study of Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone (LR-CD) for Untreated Low-Grade Non-Hodgkin Lymphoma Requiring Therapy

American Journal of Hematology
Hematology
2017English

Pembrolizumab Monotherapy in Patients With Primary Refractory Classical Hodgkin Lymphoma: Subgroup Analysis of the Phase 2 Keynote-087 Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Pegylated Liposomal Doxorubicin Combined With Cyclophosphamide, Vincristine/Vindesine, and Prednisone in Patients With Aggressive T-Cell Lymphoma: Preliminary Results of Aphase Ii Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

First Salvage Treatment With Bendamustine and Brentuximab Vedotin in Hodgkin Lymphoma: A Phase 2 Study of Fil Onlus

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Mortality Rates Remain Increased in Young Patients With Classical Hodgkin Lymphoma Even After Years in Remission: Results From a Nordic Lymphoma Group Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy